⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

EDIT News

Editas Medicine, Inc. Common Stock

Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences